Delving into the Latest Updates on Aponia Laboratories, Inc. with Synapse

概览

关联

2

项与 Aponia Laboratories, Inc. 相关的临床试验

NCT03852459 / Completed临床2期

A Randomized, Double-Blind,Vehicle-Controlled Study to Determine the Efficacy and Safety of AP0302 in the Treatment of Delayed Onset Muscle Soreness (DOMS)

Phase 2 study designed to evaluated analgesic efficacy and safety of S-Ibuprofen Topical Gel 5%

开始日期2018-01-12

申办/合作机构

Aponia Laboratories, Inc.

NCT02324985 / Completed临床2期

Phase II Study of the Effects of AP0302 5% (S-Ibuprofen Topical Gel 5%) Versus the Vehicle Control on Delayed Onset Muscle Soreness of the Elbow Flexors

This study is designed to evaluate the analgesic safety and efficacy of study drug (AP0302) applied topically every 6 hours as compared to a vehicle, in subjects experiencing delayed onset muscle soreness.

开始日期2015-01-01

申办/合作机构

Aponia Laboratories, Inc.

100 项与 Aponia Laboratories, Inc. 相关的临床结果

登录后查看更多信息

0 项与 Aponia Laboratories, Inc. 相关的专利（医药）

登录后查看更多信息

100 项与 Aponia Laboratories, Inc. 相关的药物交易

登录后查看更多信息

100 项与 Aponia Laboratories, Inc. 相关的转化医学

登录后查看更多信息